DEFA14A: Jasper Therapeutics Sets Date for 2025 Annual Stockholders Meeting

Jasper Therapeutics will hold its annual stockholders meeting virtually on July 3, 2025, to vote on director elections, auditor ratification, and executive compensation.

Summary

• Jasper Therapeutics, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on July 3, 2025, at 10:00 a.m. Pacific Time.
• Stockholders will vote on the election of three Class I directors to serve until the 2028 annual meeting.
• They will also vote to ratify the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
• Additionally, there will be advisory votes on executive compensation and the frequency of future advisory votes on executive compensation.
• The Board of Directors recommends voting FOR all director nominees, FOR Proposals 2 and 3, and ONE YEAR for Proposal 4.
• Stockholders can vote electronically during the meeting using a 12-digit control number.
• Proxy materials, including the Annual Report on Form 10-K for the year ended December 31, 2024, are available online.
• Stockholders can request a paper copy of the proxy materials by June 19, 2025.

Sentiment

Score: 7

Explanation: The document is a neutral announcement of an upcoming meeting with standard proposals. It is neither overly positive nor negative.

Positives

• The company is providing stockholders with multiple avenues to access proxy materials and vote, including online access and the option to request paper copies.
• The Board of Directors is providing clear recommendations on how to vote on each proposal.

Future Outlook

The document outlines the matters to be voted on at the upcoming annual meeting, providing a roadmap for the company's governance and financial oversight for the coming year.

Industry Context

This is a standard annual meeting announcement, typical for publicly traded companies to ensure shareholder participation in key decisions.

Stakeholder Impact

• Shareholders will have the opportunity to vote on key decisions affecting the company's direction and governance.
• The outcome of the votes will influence the composition of the Board of Directors and the selection of the company's auditor.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting on July 3, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Director Election, Executive Compensation, Auditor Ratification, Jasper Therapeutics